CorMedix Inc (CRMD) - Product Pipeline Analysis, 2018 Update

Summary

CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company’s neutrolin is a catheter lock solution for the prevention of catheter related bloodstream infections. Its neutrolin is a novel formulation of taurolidine, citrate and heparin that provides preventative solution by decreasing the triple threat of infection. CorMedix is also developing therapeutic products for the prevention and treatment of inflammatory diseases. It markets its products through its distribution network. CorMedix is headquartered in Bedminster, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company CorMedix Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

CorMedix Inc Company Overview

CorMedix Inc Company Snapshot

CorMedix Inc Pipeline Products and Ongoing Clinical Trials Overview

CorMedix Inc - Pipeline Analysis Overview

CorMedix Inc - Key Facts

CorMedix Inc - Major Products and Services

CorMedix Inc Pipeline Products by Development Stage

CorMedix Inc Ongoing Clinical Trials by Trial Status

CorMedix Inc Pipeline Products Overview

CRMD-006 - Scaffold

CRMD-006 - Scaffold Product Overview

Neutrolin

Neutrolin Product Overview

Neutrolin Clinical Trial

Taurolidine Surgical Mesh

Taurolidine Surgical Mesh Product Overview

Taurolidine Sutures

Taurolidine Sutures Product Overview

Taurolidine Wound Closures

Taurolidine Wound Closures Product Overview

Urine Labile Iron Test

Urine Labile Iron Test Product Overview

CorMedix Inc - Key Competitors

CorMedix Inc - Key Employees

CorMedix Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

CorMedix Inc, Recent Developments

Feb 20, 2018: CorMedix Achieves Target Number of Events in Its LOCK-IT-100 Study of Neutrolin for Interim Efficacy Analysis

Dec 05, 2017: Cormedix Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases

Nov 29, 2017: CorMedix to Host Seminar on Hemodialysis Catheter Complications at 17th Annual Conference on Nephrology

Sep 07, 2017: CorMedix Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris

Aug 17, 2017: CorMedix Awarded NIH Grant to Develop Advanced Antimicrobial Hydrogels for the Treatment and Prevention of Potentially Life-Threatening Infections in Severe Burns

Aug 02, 2017: Cormedix Provides Update On Neutrolin Ongoing Phase 3 Clinical Trial Following Favorable FDA Correspondence

Apr 20, 2017: Cormedix Reports Update On Neutrolin Phase 3 LOCK-IT 100 Clinical Trial

Jun 13, 2016: Cormedix Announces Publication of Pharmacoeconomic Study that Highlights the Clinical and Economic Need for Products that can Prevent Catheter-Related Bloodstream Infections

May 23, 2016: Cormedix Presented Post-Market Clinical Utility Data from Neutrolin Usage Monitoring Program at 53RD Joint Congress of the European Renal Association - European Dialysis and Transplant Association

May 18, 2016: Cormedix Announces Publication of New Pharmacoeconomic Data Demonstrating Cost of Catheter-Related Infections at the Ispor 21st Annual International Meeting

Appendix

Methodology

About

Contact

Disclaimer

List of Tables

CorMedix Inc Pipeline Products and Ongoing Clinical Trials Overview

CorMedix Inc Pipeline Products by Equipment Type

CorMedix Inc Pipeline Products by Indication

CorMedix Inc Ongoing Clinical Trials by Trial Status

CorMedix Inc, Key Facts

CorMedix Inc, Major Products and Services

CorMedix Inc Number of Pipeline Products by Development Stage

CorMedix Inc Pipeline Products Summary by Development Stage

CorMedix Inc Ongoing Clinical Trials by Trial Status

CorMedix Inc Ongoing Clinical Trials Summary

CRMD-006 - Scaffold - Product Status

CRMD-006 - Scaffold - Product Description

Neutrolin - Product Status

Neutrolin - Product Description

Neutrolin - A Novel Taurolidine Containing Catheter Lock Solution (CLS) without Reported Antimicrobial Resistance, Reduces the Rates of Infection And Thrombosis in Hemodialysis Patients Enrolled in a Post-Approval Surveillance Study (NUMP)

Neutrolin - Phase 3 Prospective, Multicenter, Double-blind, Randomized, Active Control Study to Demonstrate Safety and Effectiveness of Neutrolin in Preventing Catheter-related Bloodstream Infection in Subjects on Hemodialysis for End Stage Renal Disease